Photocure to Present at the H.C. Wainwright BioConnect 2022 Virtual Conference
Press Release – Oslo, Norway January 6, 2022, Photocure ASA (PHO:OSE): The Bladder Cancer Company focused on delivering transformative solutions to improve the lives of bladder cancer patients, announces that President and Chief Executive Officer, Dan Schneider and Chief Financial Officer, Erik Dahl are scheduled to present a corporate overview and participate in meetings with investors at the H.C. Wainwright BioConnect 2022 Virtual Conference to be held January 10-13, 2022.
- Investors may listen to the Photocure presentation online beginning on January 10 at 1:00pm CET / 7:00am ET via the following link: https://journey.ct.events/view/6e58de92-4aeb-44d6-bb5c-f815d8e7928f
- The presentation recording will be available for 90 days from the start of the conference.
Note to editors:
All trademarks mentioned in this release are protected by law and are registered trademarks of Photocure ASA
This press release may contain product details and information which are not valid, or a product is not accessible, in your country. Please be aware that Photocure does not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.
About Photocure ASA
Photocure: The Bladder Cancer Company delivers transformative solutions to improve the lives of bladder cancer patients. Our unique technology, which makes cancer cells glow bright pink, has led to better health outcomes for patients worldwide. Photocure is headquartered in Oslo, Norway, and listed on the Oslo Stock Exchange (OSE: PHO). For more information, please visit us at www.photocure.com, www.hexvix.com or www.cysview.com